Today, the U.S. Food and Drug Administration issued an
Today, the U.S. Food and Drug Administration
On December 16, 2019, the Food and Drug Adm
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the drug baricitinib, in combination
On November 26, 2018, the Food and Drug Administration granted accelerated approval to larotrectinib (VIT
Against all odds and contrary to expectations, Nigeria recently joined a few other African
BOSTON and
The U.S. Food and Drug Administration today approved Xtandi (enzalutamide) to treat
Enzalutamide and abiraterone are both types of hormone therapy that treat advanced prostate cancer.
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
